AAAAAA

   
Results: 1-9 |
Results: 9
Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument
Authors: Trope, C Kaern, J Hogberg, T Abeler, V Hagen, B Kristensen, G Onsrud, M Pettersen, E Rosenberg, P Sandvei, R Sundfor, K Vegote, I
Citation: C. Trope et al., Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument, INT J GYN C, 11, 2001, pp. 20-20
Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer
Authors: Fredstorp-Lidebring, M Bendahl, PO Brunner, N Casslen, B Hogberg, T Langstrom-Einarsson, E Willen, R Ferno, M
Citation: M. Fredstorp-lidebring et al., Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer, EUR J CANC, 37(18), 2001, pp. 2339-2348
The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of chemotherapy effects in some major tumour types - Summary and conclusions
Authors: Glimelius, B Bergh, J Brandt, L Brorsson, B Gunnars, B Hafstrom, L Haglund, U Hogberg, T Janunger, KG Jonsson, PE Karlsson, G Kimby, E Lamnevik, G Nilsson, S Permert, J Ragnhammar, P Sorenson, S Nygren, P
Citation: B. Glimelius et al., The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of chemotherapy effects in some major tumour types - Summary and conclusions, ACTA ONCOL, 40(2-3), 2001, pp. 135-154
A systematic overview of chemotherapy effects in ovarian cancer
Authors: Hogberg, T Glimelius, B Nygren, P
Citation: T. Hogberg et al., A systematic overview of chemotherapy effects in ovarian cancer, ACTA ONCOL, 40(2-3), 2001, pp. 340-360
Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument
Authors: Trope, C Kaern, J Hogberg, T Abeler, V Hagen, B Kristensen, G Onsrud, M Pettersen, E Rosenberg, P Sandvei, R Sundfor, K Vergote, I
Citation: C. Trope et al., Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument, ANN ONCOL, 11(3), 2000, pp. 281-288
Modeling normal tissue complication probability from repetitive computed tomography scans during fractionated high-dose-rate brachytherapy and external beam radiotherapy of the uterine cervix
Authors: Dale, E Hellebust, TP Skjonsberg, A Hogberg, T Olsen, DR
Citation: E. Dale et al., Modeling normal tissue complication probability from repetitive computed tomography scans during fractionated high-dose-rate brachytherapy and external beam radiotherapy of the uterine cervix, INT J RAD O, 47(4), 2000, pp. 963-971
Indications for adjuvant radiotherapy in endometrial carcinoma
Authors: Hogberg, T Fredstorp, M Jhingran, A
Citation: T. Hogberg et al., Indications for adjuvant radiotherapy in endometrial carcinoma, HEMAT ONCOL, 13(1), 1999, pp. 189
Synthesis and QSAR of substituted 3-hydroxyranthranilic acid derivatives as inhibitors of 3-hydroxyanthranilic acid dioxygenase (3-HAO)
Authors: Linderberg, M Hellberg, S Bjork, S Gotthammar, B Hogberg, T Persson, K Schwarcz, R Luthman, J Johansson, R
Citation: M. Linderberg et al., Synthesis and QSAR of substituted 3-hydroxyranthranilic acid derivatives as inhibitors of 3-hydroxyanthranilic acid dioxygenase (3-HAO), EUR J MED C, 34(9), 1999, pp. 729-744
Long-term results from a phase II study of single agent paclitaxel (Taxol (R)) in previously platinum treated patients with advanced ovarian cancer: The Nordic experience
Authors: Trope, C Hogberg, T Kaern, J Bertelsen, K Bjorkholm, E Boman, K Himmelmann, A Horvath, G Jacobsen, A Kuoppola, T Vartianen, J Lund, B Onsrud, M Puistola, U Salmi, T Scheistroen, M Sandvei, R Simonsen, E Sorbe, B Tholander, B Westberg, R
Citation: C. Trope et al., Long-term results from a phase II study of single agent paclitaxel (Taxol (R)) in previously platinum treated patients with advanced ovarian cancer: The Nordic experience, ANN ONCOL, 9(12), 1998, pp. 1301-1307
Risultati: 1-9 |